Ligand Pharm


The 3 Best Biotech Stocks to Buy as the Sector's Rally Continues

Right now, the biotech sector and Nasdaq are moving in lockstep.

Thus far in 2019, the iShares Nasdaq Biotechnology ETF (IBB) has gained 18.76%. By comparison, the technology-heavy Nasdaq index is up just over 19% this year.

Back in 1998, the same pattern was forming before biotech stocks truly broke out.

So despite the gains in the biotechnology sector in 2019, there are more gains to be had...